Concord Biotech Ltd.
CONCORDBIO Share PricePharmaceuticals & Drugs
₹1,401.6
-3.4 (-0.2%)
As on December 4, 2025
Exchange Scrips: BSE543960NSECONCORDBIOISININE338H01029
Market Cap ₹ 14,699 Cr
P/E Ratio 39.45
Dividend Yield 0.76 %
Performance
Market performance
Open1,400.2
High1,424.6
Volumes63,061
Prev1,401.6
Low1,392.4
As on2025-12-04
Historical performance
1 Year High2,451.7
3 Year High2,664
5 Year High2,664
1 Year Low1,345
3 Year Low900.05
5 Year Low900.05
Fundamentals
Company Valuation
Market Cap (₹Cr)
14,699
Face Value (₹)
1
P/E Ratio
39.45
Dividend Yield
0.76 %
Investment Returns
1 Year
-35.7%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,418.94 | Bearish |
| 10-DMA | 1,420.5 | Bearish |
| 20-DMA | 1,440.33 | Bearish |
| 50-DMA | 1,499.34 | Bearish |
| 100-DMA | 1,612.36 | Bearish |
| 200-DMA | 1,659.35 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 82644 | 82039 | 81213 | 81998 | 84292 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 39.45.
- 3Y Stock Price CAGR of the stock is 21.9.
- The stock has a beta of 0.6.
- In the last financial year, the company had an EBITDA of ₹5513 Million.
- The company generated revenue of ₹12001 Million in the previous financial year.
Concord Biotech Ltd.
1401.6-3.4 (-0.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 637569.1
No. of Shares: 455 (Approx)
Performance:-36.2%
P/L: ₹-362430.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
